메뉴 건너뛰기




Volumn 33, Issue 6, 2010, Pages

Improved glycemic control with the multi-receptor tyrosine kinase inhibitor pazopanib

Author keywords

[No Author keywords available]

Indexed keywords

EPIRUBICIN; GLIBENCLAMIDE; METFORMIN; PAZOPANIB; ANTIDIABETIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; PYRIMIDINE DERIVATIVE; SULFONAMIDE;

EID: 77956089366     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-0436     Document Type: Letter
Times cited : (12)

References (5)
  • 1
  • 2
    • 41549093594 scopus 로고    scopus 로고
    • Remission of diabetes while on sunitinib treatment for renal cell carcinoma
    • DOI 10.1093/annonc/mdn047
    • Templeton A, Brändle M, Cerny T, Gillessen S. Remission of diabetes while on sunitinib treatment for renal cell carcinoma. Ann Oncol 2008;19:824-825 (Pubitemid 351461059)
    • (2008) Annals of Oncology , vol.19 , Issue.4 , pp. 824-825
    • Templeton, A.1    Brandle, M.2    Cerny, T.3    Gillessen, S.4
  • 3
    • 14744281398 scopus 로고    scopus 로고
    • Imatinib and regression of type 2 diabetes
    • Veneri D, Franchini M, Bonora E. Imatinib and regression of type 2 diabetes. NEJM 2005;352:1049-1050
    • (2005) NEJM , vol.352 , pp. 1049-1050
    • Veneri, D.1    Franchini, M.2    Bonora, E.3
  • 5
    • 33846842100 scopus 로고    scopus 로고
    • Amelioration of diabetes by imatinib mesylate (Gleevec): Role of beta-cell NF-kappaB activation and anti-apoptotic preconditioning
    • DOI 10.1096/fj.06-6910com
    • Hägerkvist R, Sandler S, Mokhtari D, Welsh N. Amelioration of diabetes by imatinib mesylate (Gleevec): role of betacell NF-kappaB activation and anti-apoptotic preconditioning. FASEB J 2007;21: 618-628 (Pubitemid 46213508)
    • (2007) FASEB Journal , vol.21 , Issue.2 , pp. 618-628
    • Hagerkvist, R.1    Sandler, S.2    Mokhtari, D.3    Welsh, N.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.